New Real-World study tests nemolizumab for chronic itch condition

NCT ID NCT06988618

Recruiting now Symptom relief Sponsor: Galderma R&D Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how well the drug nemolizumab works for adults with moderate-to-severe prurigo nodularis, a skin condition that causes intense itching and bumps. Researchers will track 600 participants over 6 months in real-world clinics, measuring itch severity and skin lesion improvement. The goal is to see if the drug helps control symptoms in everyday practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prurigo nodularis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PRURIGO NODULARIS

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Galderma Investigation Site # 6367
RECRUITING

Rostock, Mecklenburg-Vorpommern, 18057, Germany
Galderma Investigational Site # 5437
NOT_YET_RECRUITING

Kiel, Schleswig-Holstein, 24105, Germany
Galderma Investigational Site # 6369
NOT_YET_RECRUITING

Erlangen, Bavaria, 91054, Germany
Galderma Investigational Site # 6370
NOT_YET_RECRUITING

Haslach, 77716, Germany
Galderma Investigational Site # 6371
RECRUITING

Oberursel, 61440, Germany
Galderma Investigational Site # 6373
RECRUITING

Mainz, 55128, Germany
Galderma Investigational Site # 6374
NOT_YET_RECRUITING

Karlsruhe, Baden-Wurttemberg, 76133, Germany
Galderma Investigational Site # 6384
RECRUITING

Koblenz, 56068, Germany
Galderma Investigational Site # 6385
RECRUITING

Berlin, 10117, Germany
Galderma Investigational Site # 6386
RECRUITING

Bielefeld, 33647, Germany
Galderma Investigational Site # 6387
NOT_YET_RECRUITING

Ahaus, 48683, Germany
Galderma Investigational Site # 6836
RECRUITING

Fountain Valley, California, 92708-3701, United States
Galderma Investigational Site # 7051
NOT_YET_RECRUITING

New York, New York, 10023, United States
Galderma Investigational Site # 7052
NOT_YET_RECRUITING

East Syracuse, New York, 13057, United States
Galderma Investigational Site # 7053
NOT_YET_RECRUITING

Waterford, Michigan, 48328, United States
Galderma Investigational Site # 7055
RECRUITING

Portsmouth, New Hampshire, 03801-7156, United States
Galderma Investigational Site # 7056
NOT_YET_RECRUITING

New York, New York, 10012-1354, United States
Galderma Investigational Site # 7057
NOT_YET_RECRUITING

Lee's Summit, Missouri, 64064, United States
Galderma Investigational Site # 7058
NOT_YET_RECRUITING

Chicago, Illinois, 60641, United States
Galderma Investigational Site # 7059
NOT_YET_RECRUITING

Fairfield, Connecticut, 06824, United States
Galderma Investigational Site # 7060
NOT_YET_RECRUITING

Phoenix, Arizona, 85008-3884, United States
Galderma Investigational Site # 7061
NOT_YET_RECRUITING

Castle Rock, Colorado, 80109-8034, United States
Galderma Investigational Site # 7062
NOT_YET_RECRUITING

Edinburg, Texas, 78539-4660, United States
Galderma Investigational Site # 7063
NOT_YET_RECRUITING

Cutler Bay, Florida, 33157, United States
Galderma Investigational Site # 7064
NOT_YET_RECRUITING

Santa Monica, California, 90404-2216, United States
Galderma Investigational Site # 7065
NOT_YET_RECRUITING

Brighton, Massachusetts, 02135, United States
Galderma Investigational Site # 7066
NOT_YET_RECRUITING

Auburn Hills, Michigan, 48326-3396, United States
Galderma Investigational Site # 7067
NOT_YET_RECRUITING

Tucson, Arizona, 85718, United States
Galderma Investigational Site # 7068
NOT_YET_RECRUITING

Rockville, Maryland, 20850-6243, United States
Galderma Investigational Site # 7069
NOT_YET_RECRUITING

Sugar Land, Texas, 77478-3842, United States
Galderma Investigational Site # 7070
NOT_YET_RECRUITING

North Miami Beach, Florida, 33162-4708, United States
Galderma Investigational Site # 7071
NOT_YET_RECRUITING

Caledonia, Michigan, 49316-7478, United States
Galderma Investigational Site # 7072
NOT_YET_RECRUITING

Troy, Michigan, 48084-5260, United States
Galderma Investigational Site # 7074
NOT_YET_RECRUITING

Corona, California, 92882, United States
Galderma Investigational Site # 7076
NOT_YET_RECRUITING

St Louis, Missouri, 63141-7068, United States
Galderma Investigational Site # 7077
NOT_YET_RECRUITING

Phoenix, Arizona, 85006-2754, United States
Galderma Investigational Site # 7078
NOT_YET_RECRUITING

Miami, Florida, 33173, United States
Galderma Investigational Site # 7079
NOT_YET_RECRUITING

Vienna, Virginia, 22182, United States
Galderma Investigational Site # 7080
NOT_YET_RECRUITING

Auburn, New York, 13021, United States
Galderma Investigational Site # 7081
NOT_YET_RECRUITING

Dayton, Ohio, 45414-2799, United States
Galderma Investigational Site # 7087
NOT_YET_RECRUITING

Coral Gables, Florida, 33134, United States
Galderma Investigational Site # 7088
NOT_YET_RECRUITING

Grapevine, Texas, 76051, United States
Galderma Investigational Site # 7091
NOT_YET_RECRUITING

Tampa, Florida, 33615-4537, United States
Galderma Investigational Site # 8012
NOT_YET_RECRUITING

Glendale, Maryland, 20769-9182, United States
Galderma Investigational Site # 8142
NOT_YET_RECRUITING

Indianapolis, Indiana, 46250-2041, United States
Galderma Investigational Site # 8224
NOT_YET_RECRUITING

Fremont, California, 94538-1603, United States
Galderma Investigational Site # 8238
NOT_YET_RECRUITING

Dallas, Texas, 75230-5808, United States
Galderma Investigational Site # 8282
NOT_YET_RECRUITING

Mount Kisco, New York, 10549-3035, United States
Galderma Investigational Site # 8559
NOT_YET_RECRUITING

Philadelphia, Pennsylvania, 19103-4738, United States
Galderma Investigational Site # 8893
NOT_YET_RECRUITING

Birmingham, Alabama, 35244, United States
Galderma Investigational Tracker Site # 6172
RECRUITING

Berlin, 12203, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.